Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
2 hedge funds and large institutions have $1K invested in Acer Therapeutics Inc in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 29 closing their positions.
94% less funds holding
Funds holding: 31 → 2 (-29)
100% less capital invested
Capital invested by funds: $3.4M → $1K (-$3.4M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 29
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$808K |
| 2 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$756K |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$748K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$386K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$240K |
ACER Hedge Fund Activity: Q4 2023 in Review
2 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q4 2023, worth a combined $1K — down 100% from $3.4M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of ACER and 0 opened new positions — a net loss of 29 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Yakira Capital Management, exiting entirely with an estimated $808K sold.
- 2 institutional investors held Acer Therapeutics Inc (ACER) as of Q4 2023, down from 31 in Q3 2023.
- Funds reported $1K of Acer Therapeutics Inc stock for Q4 2023, down 100% quarter-over-quarter.
- 0 funds opened new Acer Therapeutics Inc positions in Q4 2023 and 29 closed out, a net change of -29 holders.
- The largest Acer Therapeutics Inc seller in Q4 2023 was Yakira Capital Management, an estimated $808K sold.
Based on aggregated 13F filings for Q4 2023.